Ranking Alexa Global: # 6,602,057
Server:Apache...
The main IP address: 174.129.30.187,Your server United States,Ashburn ISP:Amazon.com Inc. TLD:com CountryCode:US
The description :menu home about overview management team board of directors scientific advisory board careers technology overview polyxen™ xbio-101 patents publications product pipeline overview xbio-101 polyxen rese...
This report updates in 03-Dec-2018
Created Date: | 2009-09-28 |
Changed Date: | 2018-09-28 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host xeneticbio.com. Currently, hosted in United States and its service provider is Amazon.com Inc. .
Latitude: | 39.043720245361 |
Longitude: | -77.487487792969 |
Country: | United States (US) |
City: | Ashburn |
Region: | Virginia |
ISP: | Amazon.com Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 4905 |
Content-Encoding: | gzip |
Vary: | Accept-Encoding |
Keep-Alive: | timeout=900, max=100 |
Server: | Apache |
Connection: | Keep-Alive |
X-UA-Compatible: | IE=Edge |
Date: | Mon, 03 Dec 2018 03:52:37 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | ns1.mediatemple.net. dnsadmin.mediatemple.net. 2018112901 10800 3600 1209600 43200 |
txt: | "v=spf1 include:spf.serverdata.net -all" |
ns: | ns2.mediatemple.net. ns1.mediatemple.net. |
ipv4: | IP:174.129.30.187 ASN:14618 OWNER:AMAZON-AES - Amazon.com, Inc., US Country:US IP:54.208.101.55 ASN:14618 OWNER:AMAZON-AES - Amazon.com, Inc., US Country:US |
mx: | MX preference = 10, mail exchanger = xeneticbio.com.1.0001.arsmtp.com. MX preference = 20, mail exchanger = xeneticbio.com.2.0001.arsmtp.com. |
menu home about overview management team board of directors scientific advisory board careers technology overview polyxen™ xbio-101 patents publications product pipeline overview xbio-101 polyxen research & development clinical trials recurrent or persistent endometrial cancer clinical trial partners news & media press releases presentations multimedia investors investor relations overview news / events press releases ir calendar email alerts company info profile presentations management team contacts faq analyst coverage financial info financials financial results stock data quote charts historical data sec filings all sec filings annual reports quarterly reports section 16 filings governance board of directors governance documents contact xenetic biosciences, inc. on twitter xenetic biosciences, inc. on facebook xenetic biosciences, inc. on linkedin xenetic biosciences, inc. on google+ nasdaq: xbio enhancing lives with transformative therapies xenetic biosciences is clinical-stage biopharmaceutical company focused on discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics. more about us combatting disease through innovative therapies product pipeline transformative technologies our proprietary and patented technologies are being utilized to create life-changing therapies. our novel technologies strong partnerships lead to revolutionary results we actively pursue partnerships with biotechnology and pharmaceutical companies to co-develop new product candidates and more. partnerships latest news nov 15, 2017 xenetic biosciences reports 2017 third quarter financial results and provides corporate update nov 02, 2017 xenetic biosciences enters into sublicense agreement related to its polyxen™ technology with baxalta inc., a wholly-owned subsidiary of shire plc recent event nov 28, 2018 • 10:00am est 2018 annual meeting of stockholders tweets @xeneticbio stock information • view detailed stock information nasdaq: xbio xenetic biosciences, inc. price change volume day range 52 week range get email alerts stay informed about our latest new and updates sign up today © 2018 xenetic biosciences, inc. privacy policy disclaimer sitemap
https://www.xeneticbio.com/investors/corporate-governance/board-of-directors
https://www.xeneticbio.com/investors/company-information/analyst-coverage
https://www.xeneticbio.com/investors/company-information/management-team
https://www.xeneticbio.com/about/management-team
https://www.xeneticbio.com/privacy-policy
https://www.xeneticbio.com/investors/financial-information/financial-results
https://www.xeneticbio.com/investors/sec-filings/all-sec-filings
https://www.xeneticbio.com/technology/overview
https://www.xeneticbio.com/investors/sec-filings/annual-reports
https://www.xeneticbio.com/investors/company-information/faq
https://www.xeneticbio.com/news-media
https://www.xeneticbio.com/investors/news-events
https://www.xeneticbio.com/investors/corporate-governance
https://www.xeneticbio.com/news-media/press-releases
https://www.xeneticbio.com/investors/_
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: XENETICBIO.COM
Registry Domain ID: 1570565017_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2018-09-28T18:08:29Z
Creation Date: 2009-09-28T14:28:34Z
Registry Expiry Date: 2023-09-28T14:28:34Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +33.170377661
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.MEDIATEMPLE.NET
Name Server: NS2.MEDIATEMPLE.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2019-02-04T06:09:35Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Gandi SAS
SERVERS
SERVER com.whois-servers.net
ARGS domain =xeneticbio.com
PORT 43
TYPE domain
DOMAIN
NAME xeneticbio.com
CHANGED 2018-09-28
CREATED 2009-09-28
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
NS1.MEDIATEMPLE.NET 64.207.128.246
NS2.MEDIATEMPLE.NET 70.32.65.137
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .